M. Rives

2.6k total citations
34 papers, 1.9k citations indexed

About

M. Rives is a scholar working on Surgery, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, M. Rives has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 14 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in M. Rives's work include Receptor Mechanisms and Signaling (13 papers), Head and Neck Cancer Studies (7 papers) and Neuropeptides and Animal Physiology (7 papers). M. Rives is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Head and Neck Cancer Studies (7 papers) and Neuropeptides and Animal Physiology (7 papers). M. Rives collaborates with scholars based in France, United States and Belgium. M. Rives's co-authors include Jonathan A. Javitch, Jean‐Philippe Pin, Laurent Prézeau, Eric Trinquet, Damien Maurel, Laëtitia Comps‐Agrar, Thierry Durroux, Emmanuel Bourrier, Hervé Bazin and Norbert Tinel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

M. Rives

31 papers receiving 1.9k citations

Peers

Countries citing papers authored by M. Rives

Since Specialization

Citations

This map shows the geographic impact of M. Rives's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Rives with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Rives more than expected).

Fields of papers citing papers by M. Rives

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Rives. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Rives. The network helps show where M. Rives may publish in the future.

Co-authorship network of co-authors of M. Rives

This figure shows the co-authorship network connecting the top 25 collaborators of M. Rives. A scholar is included among the top collaborators of M. Rives based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Rives. M. Rives is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	pH Dependence of a GPR4 Selective Antagonist Hampers Its Therapeutic Potential 2023 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Amy Y. Shih, Romeo Papazyan, (unknown), (unknown), Peng Hsiao, Yong Yue, Jun Yin, (unknown), (unknown), (unknown), Bryan C. Fuchs, M. Rives	5
2	Design, synthesis and preclinical evaluation of bio-conjugated amylinomimetic peptides as long-acting amylin receptor agonists 2022 ·European Journal of Medicinal Chemistry ·Raymond J. Patch, Rui Zhang, Suzanne C. Edavettal, Mark J. Macielag, Annette Eckardt, Jiali Li, M. Rives, Wilson B. Edwards, Simon A. Hinke, Xi Qiu, Wenying Jian, Ondrej Libiger, Songmao Zheng, (unknown), Yin Liang, Shamina M. Rangwala, James Leonard, Pamela J. Hornby	5
3	LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial 2020 ·Annals of Oncology ·Jean Bourhis, Clément Sire, Yungan Tao, Laurent Martin, M. Alfonsi, (unknown), M. Rives, C. Lafond, J.M. Tourani, J. Biau, L. Geoffrois, Alexandre Coutté, X. Liem, Élodie Vauléon, Franck Drouet, (unknown), J. Guigay, (unknown), A. Aupérin, (unknown)	46
4	Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients 2020 ·Cancer/Radiothérapie ·A. Modesto, (unknown), Amélie Lusque, L. Vieillevigne, (unknown), Elizabeth Moyal, Nicolas Carrère, Rosine Guimbaud, M. Rives	0
5	A computational approach yields selective inhibitors of human excitatory amino acid transporter 2 (EAAT2) 2020 ·Journal of Biological Chemistry ·Kelly L. Damm‐Ganamet, M. Rives, Alan D. Wickenden, Heather McAllister, Taraneh Mirzadegan	2
6	Cancer de l’œsophage : radio-chimiothérapie exclusive ou préopératoire ? 2019 ·Cancer/Radiothérapie ·A. Modesto, Nicolas Carrère, Rosine Guimbaud, M. Rives, Éric Deutsch, L. Quéro, G. Créhange	1
7	Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis 2019 ·iScience ·Luke A. Miles, S.J. Hermans, Gabriela A. N. Crespi, Jonathan H. Gooi, Larissa Doughty, Tracy L. Nero, (unknown), Andreas Ebneth, Berthold Wroblowski, Daniel Oehlrich, Andrés A. Trabanco, M. Rives, Inès Royaux, Nancy C. Hancock, Michael W. Parker	64
8	GPR40-Mediated Gα12 Activation by Allosteric Full Agonists Highly Efficacious at Potentiating Glucose-Stimulated Insulin Secretion in Human Islets 2018 ·Molecular Pharmacology ·M. Rives, (unknown), (unknown), Shuyuan Zhao, Jenson Qi, Éric Arnoult, (unknown), Arturo Mancini, Billy Breton, (unknown), Mark R. Player, Alessandro Pocai	22
9	Potentiating SLC transporter activity: Emerging drug discovery opportunities 2017 ·Biochemical Pharmacology ·M. Rives, Jonathan A. Javitch, Alan D. Wickenden	54
10	Radiothérapie postopératoire des carcinomes médullaires de la thyroïde à haut risque de rechute locorégionale 2016 ·Cancer/Radiothérapie ·(unknown), Slimane Zerdoud, M. Rives, Anne Laprie, Jérôme Sarini, Solange Grunenwald, Léonor Chaltiel, P. Gräff	6
11	State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281 2016 ·Molecular Pharmacology ·M. Rives, (unknown), Bin Zhu, Simon A. Hinke, Alan D. Wickenden	13
12	The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist 2014 ·Translational Psychiatry ·Madalee M. Gassaway, M. Rives, Andrew C. Kruegel, Jonathan A. Javitch, Dalibor Sameš	115
13	Identification of Novel Functionally Selective κ-Opioid Receptor Scaffolds 2013 ·Molecular Pharmacology ·Kate L. White, Alex Scopton, M. Rives, (unknown), Prabhakar R. Polepally, Peter J. Brown, (unknown), Jonathan A. Javitch, Jordan K. Zjawiony, Bryan L. Roth	116
14	6′-Guanidinonaltrindole (6′-GNTI) Is a G Protein-biased κ-Opioid Receptor Agonist That Inhibits Arrestin Recruitment 2012 ·Journal of Biological Chemistry ·M. Rives, (unknown), Lee‐Yuan Liu‐Chen, Jonathan A. Javitch	93
15	Quality of life in patients treated for advanced hypopharyngeal or laryngeal cancer 2011 ·European Annals of Otorhinolaryngology Head and Neck Diseases ·(unknown), Benoît Lepage, Virginie Woisard, M. Rives, É. Serrano, S. Vergèz	35
16	Benefits of Perineal Colostomy on Perineal Morbidity After Abdominoperineal Resection 2010 ·Diseases of the Colon & Rectum ·Sylvain Kirzin, F Lazorthes, (unknown), M. Rives, Rosine Guimbaud, G. Portier	12
17	Time-resolved FRET between GPCR ligands reveals oligomers in native tissues 2010 ·Nature Chemical Biology ·Laura Albizu, Martin Cottet, Michaela Králíková, Stoytcho Stoev, René Seyer, Isabelle Brabet, Thomas Roux, Hervé Bazin, Emmanuel Bourrier, Laurent Lamarque, Christophe Breton, M. Rives, Amy Hauck Newman, Jonathan A. Javitch, Eric Trinquet, Maurice Manning, Jean‐Philippe Pin, Bernard Mouillac, Thierry Durroux	262
18	G‐protein‐coupled receptor oligomers: two or more for what? Lessons from mGlu and GABA_B receptors 2009 ·The Journal of Physiology ·Jean‐Philippe Pin, Laëtitia Comps‐Agrar, Damien Maurel, Carine Monnier, M. Rives, Eric Trinquet, Julie Kniazeff, Philippe Rondard, Laurent Prézeau	42
19	Functional crosstalk between GPCRs: with or without oligomerization 2009 ·Current Opinion in Pharmacology ·Laurent Prézeau, M. Rives, Laëtitia Comps‐Agrar, Damien Maurel, Julie Kniazeff, Jean‐Philippe Pin	84
20	Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization 2008 ·Nature Methods ·Damien Maurel, Laëtitia Comps‐Agrar, Carsten Brock, M. Rives, Emmanuel Bourrier, Mohammed Akli Ayoub, Hervé Bazin, Norbert Tinel, Thierry Durroux, Laurent Prézeau, Eric Trinquet, Jean‐Philippe Pin	393

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact